Coloplast A/s Class B · OMXCOP:COLO_B

Coloplast A/s Class B — FY2014/15 Earnings Presentation

7 slides from Coloplast A/s Class B's earnings presentation, Nov 3, 2015

  1. Slide 1: Coloplast Earnings Conference Call FY 2014/15

    NEW! SenSura® Mio Convex Coloplast Earnings Conference Call FY 2014/15 3 November 2015

  2. Slide 2: Forward-looking statements

    Forward-looking statements The forward-looking statements contained in this presentation, including forecasts of sales and earnings performance, are not guarantees of future results and are subject to risks, uncertainties and assumptions that are difficult to predict. The forward-looking statements

  3. Slide 3: FY 2014/15 organic growth of 7% and 33% EBIT margin before special items

    FY 2014/15 organic growth of 7% and 33% EBIT margin before special items in a challenging year for Coloplast Highlights Performance  Organic revenue growth of 7% (12% in Revenue (mDKK) DKK) Organic growth (%)  Gross margin of 69% on par with last year 9  EBIT margin before special items of 33% 25

  4. Slide 4: FY 2014/15 7% organic growth in line with guidance in a market growing ~5%

    FY 2014/15 7% organic growth in line with guidance in a market growing ~5% FY 14/15 revenue by business area FY 14/15 revenue by geography Business Reported revenue Organic growth Geographic Reported revenue Organic growth area mDKK In percent area mDKK In percent Ostomy European 5% 5,567 6% 8,843 C

  5. Slide 5: Strong Q4 with 34% EBIT margin before special items

    Strong Q4 with 34% EBIT margin before special items Highlights 2014/15 Performance drivers Q4 2014/15  EBIT before special items grew 9% to DKK EBIT Margin Q4 2013/14 34.2% 4,535m with a margin of 33%  Gross margin of 69% on par with last year ∆ Gross profit margin  Driven by continued efficiency

  6. Slide 6: Financial guidance for 2015/16 in line with long term ambition

    Financial guidance for 2015/16 in line with long term ambition Guidance Guidance Long term 15/16 15/16 (DKK) ambition Sales growth 7-8% (organic) 8-9% 7-10% p.a. EBIT margin 33-34% (fixed) 33-34% +50-100 bps p.a. CAPEX (DKKm) ~700 ~4-5% of sales Tax rate ~23% - Page 6

  7. Slide 7: Our mission, values and vision

    Our mission Making life easier for people with intimate healthcare needs Our values Closeness… to better understand Passion… to make a difference Respect and responsibility… to guide us Our vision Setting the global standard for listening and responding Page 7

Coloplast — FY2014/15 Earnings Presentation on 6ix